Quality control of the technology method of clinical comprehensive drug evaluation

WANG Shu; DONG Mingyang; CHEN Pengjun; JIAN Lingyan

doi:10.6039/j.issn.1001-0408.2023.03.04

您当前的位置：

首页 >

文章列表页 >

Quality control of the technology method of clinical comprehensive drug evaluation

更新时间：2023-02-22

- Quality control of the technology method of clinical comprehensive drug evaluation
- ZHONGGUO YAOFANG Vol. 34, Issue 3, Pages: 275-279(2023)
- 作者机构：
  
  中国医科大学附属盛京医院药学部，沈阳　110004
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2023.03.04
  CLC： R95;R969.3
- Published：15 February 2023，
  
  Received：08 July 2022，
  
  Revised：13 January 2023，
扫描看全文
王舒,董名扬,陈朋军等.药品临床综合评价技术方法的质量控制 ^Δ[J].中国药房,2023,34(03):275-279.

WANG Shu,DONG Mingyang,CHEN Pengjun,et al.Quality control of the technology method of clinical comprehensive drug evaluation[J].ZHONGGUO YAOFANG,2023,34(03):275-279.
王舒,董名扬,陈朋军等.药品临床综合评价技术方法的质量控制 ^Δ[J].中国药房,2023,34(03):275-279. DOI： 10.6039/j.issn.1001-0408.2023.03.04.

WANG Shu,DONG Mingyang,CHEN Pengjun,et al.Quality control of the technology method of clinical comprehensive drug evaluation[J].ZHONGGUO YAOFANG,2023,34(03):275-279. DOI： 10.6039/j.issn.1001-0408.2023.03.04.

摘要

我国药品临床综合评价工作目前还存在诸如评价内容设计不科学、评价方法和组织流程欠规范、评价结果无法满足决策需求等问题，亟须对药品临床综合评价项目的全过程进行质量控制。本文从技术角度出发，从评价内容与设计（给出主题遴选流程和方案设计的质量控制要点）、评价方法（探讨2种常用评价方法——文献证据法和真实世界研究的质量控制要素）、结果应用转化（从评价结果综合分析、评价结果转化与决策两方面给出质量控制的建议）3个环节探讨药品临床综合评价的质量控制方法，拟促进该项工作的质量提升。

Abstract

At present， there are still some problems in China’s clinical comprehensive drug evaluation， such as the unscientific design of the evaluation content， the nonstandard evaluation method and organizational process， and the evaluation results not meeting the decision-making needs. It is urgent to carry out quality control over the whole process of the clinical comprehensive drug evaluation project. From the technical point of view， the quality control methods of clinical comprehensive drug evaluation are discussed through three links of the evaluation content and design （giving the quality control key points of the theme selection process and scheme design）， the evaluation method （discussing the quality control elements of two common evaluation methods， i.e. documentary evidence method and real-world research） and result application transformation （giving suggestions on quality control from the comprehensive analysis of evaluation results， transformation of evaluation results and decision-making）， so as to promote the quality improvement of clinical comprehensive drug evaluation.

关键词

药品临床综合评价技术方法质量控制

Keywords

technical methodquality control

references

国家卫生健康委药物政策与基本药物制度司.国家卫生健康委办公厅关于规范开展药品临床综合评价工作的通知[EB/OL]. （2021-07-28）[2022-07-08]. http：//www.nhc.gov.cn/yaozs/s2908/202107/532e20800a47415d84adf-3797b0f4869.shtmlhttp://www.nhc.gov.cn/yaozs/s2908/202107/532e20800a47415d84adf-3797b0f4869.shtml.

国家卫生健康委药政司.药品临床综合评价管理指南：试行[EB/OL].（2020-11-04）[2022-07-08].http：//www.nhc.gov.cn/cms-search/xxgk/getManuscriptXxgk.htm?id=d11ddc32fae84121a0dfca36b015a31dhttp://www.nhc.gov.cn/cms-search/xxgk/getManuscriptXxgk.htm?id=d11ddc32fae84121a0dfca36b015a31d.

国家药物和卫生技术综合评估中心. 国家药物和卫生技术综合评估中心关于发布心血管病、抗肿瘤、儿童药品临床综合评价技术指南的通知[EB/OL].（2022-06-29）[2022-07-08]. https：//mp.weixin.qq.com/s/kfelcNNn6RaqBUmWgkLMhQhttps://mp.weixin.qq.com/s/kfelcNNn6RaqBUmWgkLMhQ.

赵锐，胡若飞，石秀园，等. 我国药品临床综合评价全面质量管理体系的构建[J]. 中国药房， 2022， 33（12）： 1409-1414， 1429.

邱英鹏，赵琨，王晓玲，等. 儿童药品临床综合评价主题的遴选方法初探[J]. 中国药物评价， 2021， 38（3）： 177-182.

贾露露，尉耘翠，刘亦韦，等. 探索中国儿童用药临床综合评价体系的建立方法和路径[J]. 国际药学研究杂志， 2016， 43（4）： 585-590.

Agree Collaboration. Appraisal of guidelines for research and evaluation in Europe Ⅱ （AGREE Ⅱ） instrument[EB/OL]. [2022-07-08]. https：//www.agreetrust.org/wp-content/uploads/2017/12/AGREE-II-Users-Manual-and-23-item-Instrument-2009-Update-2017.pdfhttps://www.agreetrust.org/wp-content/uploads/2017/12/AGREE-II-Users-Manual-and-23-item-Instrument-2009-Update-2017.pdf.

INAHTA. A checklist for health technology assessment reports[EB/OL].[2022-07-08]. http：//www.inahta.org/hta-tools-resources/briefs/http://www.inahta.org/hta-tools-resources/briefs/.

张方圆，沈傲梅，曾宪涛，等. 系统评价方法学质量评价工具AMSTAR 2解读[J]. 中国循证心血管医学杂志， 2018， 10（1）： 14-18.

HUSEREAU D， DRUMMOND M， PETROU S， et al. Consolidated health economic evaluation reporting standards （CHEERS）：explanation and elaboration： a report of the ISPOR health economic evaluation publication guidelines good reporting practices task force[J]. Value Health， 2013， 16（2）： 231-250.

刘括，孙殿钦，廖星，等.随机对照试验偏倚风险评估工具2.0修订版解读[J].中国循证心血管医学杂志，2019，11（3）：284-291.

WELLS G，SHEA B，O’CONNELL D，et al. The New- castle-Ottawa scale （NOS） for assessing the quality of case-control studies in meta-analyses[J]. Eur J Epidemiol， 2011， 25：603-605.

刘玉强，乔瑞，卓琳，等. 真实世界数据在上市后药品安全性研究中的伦理风险[J]. 中国药物警戒， 2021， 18（7）： 628-631.

于玥琳，卓琳，孟若谷，等. 真实世界数据适用性评价方法的研究进展与前景挑战[J]. 中华流行病学杂志， 2022， 43（4）： 578-585.

IMPROTA G， PERRONE A， RUSSO M A， et al. Health technology assessment （HTA） of optoelectronic biosensors for oncology by analytic hierarchy process （AHP） and Likert scale[J]. BMC Med Res Methodol， 2019， 19（1）： 140.

董名扬，王舒，菅凌燕. 药品临床综合评价方法的应用现状[J]. 中国药房， 2021， 32（22）： 2813-2816.

CAMPOS M， JIMENEZ F， SANCHEZ G， et al. A metho- dology based on multiple criteria decision analysis for combining antibiotics in empirical therapy[J]. Artif Intell Med， 2020， 102： 101751.

江苏省卫生健康委办公室.关于印发江苏省药品临床综合评价项目质量控制指南（试行）的通知：苏卫办药政〔2021〕13号 [EB/OL]. （2022-04-27）[2022-07-08]. http：//jspchfp.jiangsu.gov.cn/art/2022/4/27/art_7335_10432743.htmlhttp://jspchfp.jiangsu.gov.cn/art/2022/4/27/art_7335_10432743.html.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Extraction， isolation， identification and content determination of four chemical components in Yao medicine Ventilago leiocarpa

Study on quality control method of the roots and rhizoma of Toricellia angulata

Identification of components， fingerprint and content determination of the effective parts of Dracocephalum moldavica

Study on quality control method of Qiguiling mixture

Research progress on harvesting and processing methods and quality control of Moutan Cortex

Related Author

XIA Xueqing

HUANG Jianyou

HUANG Zhoufeng

GAO Meimei

HUANG Hongmiao

LU Guoshou

LI Xue

NIE Yushan

Related Institution

College of Pharmacy， Guangxi University of Chinese Medicine

Guangxi Zhuang Autonomous Region Institute of Traditional Medical and Pharmaceutical Sciences

Guangxi Key Laboratory of Traditional Chinese Medicine Quality Standards

Engineering Research Center for the Development and Application of Ethnic Medicine and TCM/State Key Laboratory of Functions and Applications of Medicinal Plants， Guizhou Medical University

School of Pharmacy， Guizhou Medical University

Address：8/F,129 Daping Main Street,Yuzhong District,Chongqing 400042,P.R.China
Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号公网安备50010302001817
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰